NASDAQ
Humacyte, Inc. (HUMA) reported revenue of $2.04M and net income of $-40,833,000 for FY 2025, with a net profit margin of -2003.6%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.